Cell And Gene Therapy Contract Research Organization Market Report 2026

Cell And Gene Therapy Contract Research Organization Market Overview

• Cell And Gene Therapy Contract Research Organization market size has reached to $6.92 billion in 2025 • Expected to grow to $12.36 billion in 2030 at a compound annual growth rate (CAGR) of 12.3% • Growth Driver: The Rising Focus On Personalized Medicine And Targeted Therapeutics Fueling The Growth Of The Market Due To Increasing Adoption Of Precision-Based Drug Development • Market Trend: Technology Expansion Improves End-to-End Development Support for Advanced Therapies • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cell And Gene Therapy Contract Research Organization Market?

Cell and gene therapy contract research organization refers to a specialized external research entity that provides comprehensive research and development support for advanced cell-based and gene-based therapeutic products. These organizations assist across preclinical and clinical stages by offering scientific expertise, regulatory support, and study management tailored to complex biological therapies. They enable developers to accelerate innovation, reduce development risk, and achieve efficient progression from early research to clinical evaluation. The main types of cell and gene therapy contract research organization (CRO) include preclinical contract research organizations, clinical stage contract research organizations, and other types. Preclinical contract research organizations refer to organizations that provide laboratory and animal model studies to evaluate the safety and efficacy of cell and gene therapies before human clinical trials. These organizations offer services such as project and clinical trial management, regulatory strategy, data management and medical writing, clinical monitoring, quality management and good manufacturing practice compliance, biostatistics and safety monitoring, patient and site recruitment, technology transfer, and other services. They support therapeutic indications including oncology, central nervous system disorders, infectious diseases, immunological disorders, cardiovascular diseases, respiratory diseases, diabetes, ophthalmology, pain management, and other indications. They are applied across modalities such as cell-based therapies, gene therapies, and gene-modified cell therapies, and are used in applications including hospitals, research institutes, and other applications.

What Is The Cell And Gene Therapy Contract Research Organization Market Growth Forecast?

The cell and gene therapy contract research organization market size is expected to see rapid growth in the next few years. It will grow to $12.36 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to increasing clinical trial activity in gene therapies, expansion of personalized medicine development, rising investments in oncology and genetic disorder research, growing demand for accelerated development timelines, increasing collaboration between biotech firms and CROs. Major trends in the forecast period include increasing outsourcing of cell and gene therapy research, rising demand for integrated preclinical and clinical services, growing focus on regulatory and compliance expertise, expansion of vector development and manufacturing support, enhanced use of data-driven trial management.

Global Cell And Gene Therapy Contract Research Organization Market Segmentation

1) By Type: Preclinical Contract Research Organization; Clinical Stage Contract Research Organization; Other Types 2) By Service: Project And Clinical Trial Management; Regulatory Strategy; Data Management And Medical Writing; Clinical Monitoring; Quality Management And Good Manufacturing Practice Compliance; Biostatistics And Safety Monitoring; Patient And Site Recruitment; Technology Transfer; Other Services 3) By Indication: Oncology; Central Nervous System Disorders; Infectious Diseases; Immunological Disorders; Cardiovascular Diseases; Respiratory Diseases; Diabetes; Ophthalmology; Pain Management; Other Indications 4) By Modality: Cell-Based Therapies; Gene Therapies; Gene-Modified Cell Therapies 5) By Application: Hospital; Research Institute; Other Applications Subsegments: 1) By Preclinical Contract Research Organization: In Vitro Testing Services; In Vivo Animal Model Services; Toxicology And Safety Assessment; Other Preclinical Services 2) By Clinical Stage Contract Research Organization: Phase I Clinical Trial Services; Phase II Clinical Trial Services; Phase III Clinical Trial Services; Other Clinical Stage Services 3) By Other Types: Regulatory Consulting Services; Process Development Services; Manufacturing Support Services; Other Support Services

What Is The Driver Of The Cell And Gene Therapy Contract Research Organization Market?

The rising focus on personalized medicine and targeted therapeutics is expected to propel the growth of the cell and gene therapy contract research organization (CRO) market going forward. Personalized medicine and targeted therapeutics involve the development of treatments tailored to individual genetic, molecular, or cellular characteristics to improve efficacy and reduce adverse effects. The focus on personalized medicine is increasing as regulators and healthcare systems prioritize precision-based therapies to address complex diseases and achieve higher clinical success rates. Cell and gene therapy contract research organizations (CROs) support personalized medicine by providing specialized preclinical, clinical, and regulatory services required to develop, test, and validate complex gene- and cell-based therapeutic products. For instance, in April 2025, according to the Personalized Medicine Coalition, a US-based nonprofit organization, the Food and Drug Administration (FDA) approved 18 personalized medicines in 2024, accounting for approximately 38% of all newly approved therapeutic molecular entities. Therefore, the rising focus on personalized medicine and targeted therapeutics is driving the growth of the cell and gene therapy contract research organization (CRO) market.

Key Players In The Global Cell And Gene Therapy Contract Research Organization Market

Major companies operating in the cell and gene therapy contract research organization market are Thermo Fisher Scientific Inc., IQVIA Holdings Inc., Laboratory Corporation of America Holdings (Labcorp), ICON plc, WuXi AppTec Co. Ltd., Syneos Health Inc., Charles River Laboratories International Inc., Parexel International Corporation, Fortrea Holdings Inc., CMIC Co. Ltd., Medpace Holdings Inc., PharmaLex GmbH, Premier Research International LLC, Worldwide Clinical Trials Inc., Novotech (Australia) Pty Ltd., Precision for Medicine Inc., Syngene International Limited, Allucent Inc., TFS HealthScience AB, QPS Holdings LLC, Altasciences Company Inc., Veristat LLC, Linical Co. Ltd., Aixial Group, ProRelix Research LLC

Global Cell And Gene Therapy Contract Research Organization Market Trends and Insights

Major companies operating in the cell and gene therapy contract research organization (CRO) market are focusing on developing innovative solutions such as expanded laboratory and analytical services to enhance therapy development efficiency, regulatory compliance, and research precision by providing state-of-the-art facilities, specialized equipment, and integrated cell and gene therapy testing capabilities. Expanded laboratory and analytical services refer to contract research organization (CRO) offerings that increase capacity, enable complex assay execution, and support sponsors with end-to-end development of advanced cell and gene therapies. For instance, in August 2025, Labcorp Holdings Inc., a US-based healthcare company, expanded its cell and gene therapy laboratory in madison, wisconsin, enhancing its capabilities for cell characterization, vector analytics, and regulatory-compliant testing. The expanded facility provides specialized infrastructure for complex cell and gene therapy workflows, supports high-throughput sample processing, and integrates advanced analytical platforms, making it a comprehensive solution for accelerating cell and gene therapy research and development.

What Are Latest Mergers And Acquisitions In The Cell And Gene Therapy Contract Research Organization Market?

In January 2023, Novotech Clinical Research, a Singapore-based full-service contract research organization (CRO), acquired EastHORN Clinical Services for an undisclosed amount. Through this acquisition, novotech aims to strengthen its global operations by integrating easthorn’s clinical, medical, and regulatory expertise across Europe, enabling seamless delivery of early- to late-phase clinical development services for its biotech clients. EastHORN Clinical Services is a Poland-based contract research organization (CRO) that provides clinical, medical, and regulatory support for cell and gene therapy development as part of global clinical trial programs.

Regional Insights

North America was the largest region in the cell and gene therapy contract research organization (CRO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cell And Gene Therapy Contract Research Organization Market?

The cell and gene therapy contract research organization market includes revenues earned by entities through preclinical research services, clinical trial management, vector development and manufacturing support, regulatory and compliance services, and bioanalytical and biomarker testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cell And Gene Therapy Contract Research Organization Market Report 2026?

The cell and gene therapy contract research organization market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell and gene therapy contract research organization industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.